Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Goldman Sachs Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Tipranks - Wed Feb 25, 2:28AM CST

Goldman Sachs analyst Richard Felton maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €40.00.

Claim 50% Off TipRanks Premium

Felton covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care AG & Co. KGaA, GN Store Nord, and Demant. According to TipRanks, Felton has an average return of 4.8% and a 55.08% success rate on recommended stocks.

In addition to Goldman Sachs, Fresenius Medical Care AG & Co. KGaA also received a Hold from Barclays’s Hassan Al-Wakeel in a report issued today. However, on the same day, Jefferies maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

The company has a one-year high of €54.02 and a one-year low of €35.67. Currently, Fresenius Medical Care AG & Co. KGaA has an average volume of 876.3K.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.